[Advances in research on the MAPK signal transduction pathway of Echinococcus].

Mitogen-activated protein kinase (MAPK) is an important signaling transduction molecules, which can enter the nucleus and activate target gene when it was stimulated and become phosphorylation. MAPK signaling pathway is closely associated with various diseases. Recent studies have indicated that MAPK signaling transduction pathway is also involved in the growth and development of Echinococcus. This review summarizes the progress on the relationship between MAPK signal pathway and Echinococcus.

[Inhibition of invasive growth and metastasis of hepatic alveolar echinococcosis by anti-osteopontin antibody].

OBJECTIVE: To observe the inhibitive effect on invasive growth and metastasis of Echinococcus multilocularis by exogenous anti-osteopontin (OPN) antibody. METHODS: 180 gerbils were infected with 20% E. multilocularis suspension (approximately 400 protoscoleces in 0.1 ml per gerbil) through abdominal opening injection in liver, and then divided into model group, experiment group and control group. Experiment group and control group each with 60 gerbils were injected via the tail vein with 0.15 ml of anti-OPN antibody (1:32) and rabbit serum, respectively. All gerbils in the two groups received injections, with 2-day interval for the first seven injections, and then at 7-day interval for the remaining injections. Model group were without any treatment. The three groups were subdivided into six groups each with 10 gerbils. The gerbils from each group were sacrificed on day 1, 20, 40, 60, 80, and 100 after infection, respectively. Hepatic echinococcus cyst and metastasis tissue were observed. The expression of OPN was measured by immunohistochemistry staining (SP method). Serum samples were collected at 100 d post-infection, and the content of OPN in sera was measured by ELISA. RESULTS: There were no significant difference in cyst weight and metastatic rate of thoracic lymph node among the three groups at 1, 20, 40, 60, and 80d post-infection (P > 0.05), while at 100 d postinfection, cyst weight and metastatic rate of thoracic lymph node in experiment group [(7.28 +/- 0.38) g, 20%] were lower than that of control group [(9.70 +/- 0.61) g, 70%] and model group [(932 +/- 0.73) g, 70%] (P < ). Expression of OPN was found at different levels in echinococcus cysts. OPN was located in the cytoplasm, and mainly distributed in the germinal layer. The OPN positive expression levels were not significantly different between experiment group and other groups on day 1, 20, 40, 60, and 80 afer infection ( >0 . 05). At 100d post-infection, OPN positive expression rate and serum OPN content in experimental group [20% and (30.90 +/- 2.25) ng/.l micro respectively] was lower than that of control group [80% and (41.03.2 +/- 76) nWng/micro and model group [80% and (42.39 +/- 2.85) nWng/micro (PdL < 0.). CONCLUSION: Anti-osteopontin antibody can reduce OPN concentration in hepatic echinococcus cyst and serum, and inhibit the invasive growth and metastasis of E. multilocularis.

[Effect of the liposome albendazole and Huai-Er fungus extract on hepatic infection of Echinococcus granulosus in mice].

OBJECTIVE: To explore the effect of Huai-Er fungus extract (HEF) and liposome albendazole (L-ABZ) on the hepatic infection of Echinococcus granulosus (Eg) in mice, and understand the influence of improved host immunity on postoperative recurrence. METHODS: Female Kunming mice were immune by intraperitoneal injection Eg cyst fluid from sheep, IgG positive mice were divided into drug treatment groups (A, B and C) and control group (D). Mice in group A were administered by gavage with single L-ABZ (75 mg/kg), group B with single HEF (15,000 mg/kg), and group C with combination therapy (L-ABZ 75 mg/kg plus HEF 15,000 mg/kg), once every two days for one week. The protoscoleces were treated with balanced solution for 20 minute and inoculated in the liver by open abdomen of the anesthetized mice. Imitating to an "open sub-adventitial total exocystectomy", protoscoleces outside the cyst led to a reinfection. 72 hours later, groups A, B and C were re-treated for a month. Mice in group D were given with distilled water (0.3 ml per mouse). Group E was set as blank control (n=8). Another 120 IgG positive mice were divided as groups F, G, H and I, and treated in parallel with the groups A, B, C and D respectively; these mice were inoculated with protoscoleces which were treated in advance with 75% alcohol, 20% hypertonic saline, L-ABZ and PBS for 20 min respectively. In 3 months after infection, all the mice were sacrificed to evaluate the efficacy, which covered infection rate, pathological change, spleen index, level of IgG and IgE, CD4+ and CD8+ cells. RESULTS: The recurrence rate in group C (5.7%) was lower than that of groups A (17.1%) and B (24.2%), with hydatid cysts in white colour and nodular, showing degeneration of the germinal and laminated layers. Groups A, B and C showed lower spleen index (A: 3.84+/-0.86, B: 3.95+/-1.01, and C: 3.27+/-0.52), and lower IgE level (A: 0.06+/-0.08, B: 0.07+/-0.08 and C: 0.03+/-0.03) than group D (5.46+/-0.52 and 0.20+/-0.02, respectively) (P<0.05), especially in group C; and also lowerCD8+ in groups A (16.61+/-3.89), B (18.18+/-3.90) and C (15.38+/-2.63) than group D (32.90+/-4.71) (P<0.05), but higher CD4+/CD8+ in groups A (3.21+/-0.70), B (3.05+/-0.66) and C (3.53+/-0.57) than group D (1.57+/-0.26) (P<0.05), especially in group C. The infection rate of mice in group F, Gand H was 0, 0 and 23.1% respectively, and that of group I, 31.2% (P<0.01). CONCLUSION: The combination of HEF and L-ABZ considerably improves the immunity of the hosts and HEF may have a synergetic action to L-ABZ in reducing the recurrence of "sub-adventitial total exocystectomy". 75% alcohol and 20% hypertonic saline show better effect of inactivating protoscoleces than L-ABZ in surgical operation.

[Research progress on the immunity of hepatic echinococcosis in human].

This article reviews immunological research progress in cystic echinococcosis: the immunity to Echinococcus granulosus infection, innate resistance, immune evasion mechanism. A better understanding for the immunology in human echinococcosis may help develop therapeutic and preventive agents.

Efficacy of Albendazole-Chitosan Microsphere-based Treatment for Alveolar Echinococcosis in Mice.

This study aimed to investigate the pharmacology and anti-parasitic efficacy of albendazole-chitosan microspheres (ABZ-CS-MPs) for established intraperitoneal infections of Echinococcus multilocularis metacestodes in an experimental murine model. Male outbred Kunming mice infected with E. multilocularis Metacestodes were administered with three ABZ formulations, namely, ABZ-CS-MPs, Liposome-Albendazole (L-ABZ), and albendazole tablet (ABZ-T). Each of the ABZ formulations was given orally at three different doses of 37.5, 75, and 150 mg/kg, three times a week for 12 weeks postinfection. After administering the drugs, we monitored the pharmacological performance and anti-parasitic efficacy of ABZ-CS-MPs compared with L-ABZ, and ABZ-T treated mice. ABZ-CS-MPs reduced the weight of tissues containing E. multilocularis metacestodes most effectively compared with the ABZ-T group and untreated controls. Metacestode grown was Highly suppressed during treatment with ABZ-CS-MPs. Significantly higher plasma levels of ABZ metabolites were measured in mice treated with ABZ-CS-MPs or L-ABZ compared with ABZ-T. In particular, enhanced ABZ-sulfoxide concentration profiles were observed in the mice given 150 mg/kg of ABZ-CS-MPs, but not in the mice treated with L-ABZ. Histological examination showed that damages caused disorganization of both the germinal and laminated layers of liver hyatid cysts, demolishing their characteristic structures after treatment with ABZ-CS-MPs or L-ABZ. Over time, ABZ-CS-MPs treatment induced a shift from Th2-dominant to Th1-dominant immune response. CS-MPs As a new carrier exhibited improved absorption and increased bioavailability of ABZ in the treatment of E. multilocularis infections in mice.